Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

Stereotactic body radiotherapy was associated with significantly better urinary continence and fewer sexual issues at 2 years ...

In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...

Men with prostate cancer diagnosed at an early stage may be able to slow the progression of their disease by adopting a ...

Increase of 11,000 cases means more men face risk of deadlier late-stage disease ...

Researchers developed an approach to treating prostate cancer, successfully eliminating cancerous cells in 73% of patients in ...

In a study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.

Exclusive: “Unfortunately, most of the genetic research that had been published focused only on people of white, European ...

Permanent Secretary in the Ministry of Health, Dr. Laura Esprit has said that breast cancer continues to be a major concern ...

At the moment, patients must request a blood test from their doctor, but Prostate Cancer UK is calling for change.

More than 52,000 people are diagnosed with prostate cancer every year, making it the most common cancer that affects men.